Search Results - Beck, J.
- Showing 1 - 2 results of 2
-
1
Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative ef... by Kohrt, Lisa-Madeleine (Author) , Gladbach, Yvonne S. (Author) , Ernst, M. (Author) , Hamed, M. (Author) , Roolf, C. (Author) , Sender, S. (Author) , Beck, J. (Author) , Schütz, E. (Author) , Fischer, Sarah (Author) , Struckmann, Stephan (Author) , Junghanss, C. (Author) , Fuellen, G. (Author) , Murua Escobar, H. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation... by Fischer, Thomas (Author) , Reifenrath, C. (Author) , Hess, G. R. (Author) , Corsetti, M. T. (Author) , Kreil, Sebastian (Author) , Beck, J. (Author) , Meinhardt, P. (Author) , Beltrami, G. (Author) , Schuch, B. (Author) , Gschaidmeier, Harald (Author) , Hehlmann, Rüdiger (Author) , Hochhaus, Andreas (Author) , Carella, Angelo M. (Author) , Huber, C. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource